These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17404843)

  • 21. Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation.
    Cermenati G; Abbiati F; Cermenati S; Brioschi E; Volonterio A; Cavaletti G; Saez E; De Fabiani E; Crestani M; Garcia-Segura LM; Melcangi RC; Caruso D; Mitro N
    J Lipid Res; 2012 Feb; 53(2):300-10. PubMed ID: 22158827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats.
    Cameron NE; Dines KC; Cotter MA
    Diabetologia; 1994 Dec; 37(12):1209-15. PubMed ID: 7895950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
    Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and stability of internodal myelin in mouse models of hereditary neuropathy.
    Avila RL; Inouye H; Baek RC; Yin X; Trapp BD; Feltri ML; Wrabetz L; Kirschner DA
    J Neuropathol Exp Neurol; 2005 Nov; 64(11):976-90. PubMed ID: 16254492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats.
    Suh KS; Oh SJ; Woo JT; Kim SW; Yang IM; Kim JW; Kim YS; Choi YK; Park IK
    Korean J Intern Med; 1999 Jul; 14(2):34-40. PubMed ID: 10461423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
    Kappelle AC; Bravenboer B; van Buren T; Traber J; Erkelens DW; Gispen WH
    Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary demyelination induced by exposure to tellurium alters mRNA levels for nerve growth factor receptor, SCIP, 2',3'-cyclic nucleotide 3'-phosphodiesterase, and myelin proteolipid protein in rat sciatic nerve.
    Toews AD; Eckermann CE; Roberson MD; Lee SY; Morell P
    Brain Res Mol Brain Res; 1991 Oct; 11(3-4):321-5. PubMed ID: 1721994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene probe for P0 messenger RNA used to index acrylamide toxic neuropathy in rats.
    Veronesi B; Jones K; Gupta S; Pringle J; Mezei C
    Neurotoxicology; 1991; 12(4):715-32. PubMed ID: 1724557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.
    Jolivalt CG; Fineman M; Deacon CF; Carr RD; Calcutt NA
    Diabetes Obes Metab; 2011 Nov; 13(11):990-1000. PubMed ID: 21635674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization.
    Cameron NE; Cotter MA; Dines KC; Maxfield EK
    Diabetologia; 1993 Jun; 36(6):516-22. PubMed ID: 8335173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.
    Matsumoto T; Ono Y; Kurono M; Kuromiya A; Nakamura K; Bril V
    J Pharmacol Sci; 2009 Feb; 109(2):203-10. PubMed ID: 19212096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control.
    Gupta SK; Pringle J; Poduslo JF; Mezei C
    J Neurochem; 1991 May; 56(5):1754-62. PubMed ID: 1707441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
    Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
    Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
    Dines KC; Cotter MA; Cameron NE
    Diabetologia; 1993 Nov; 36(11):1132-8. PubMed ID: 8270127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats.
    Robertson S; Cameron NE; Cotter MA
    Diabetologia; 1992 Dec; 35(12):1113-7. PubMed ID: 1478362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.
    Takata H; Takeda Y; Zhu A; Cheng Y; Yoneda T; Demura M; Yagi K; Karashima S; Yamagishi M
    Diabetes Obes Metab; 2012 Feb; 14(2):155-62. PubMed ID: 21951301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.